Related references
Note: Only part of the references are listed.Inhibition of c-Jun N-Terminal Kinase Activation Reverses Alzheimer Disease Phenotypes in APPswe/PS1dE9 Mice
Qiong Zhou et al.
ANNALS OF NEUROLOGY (2015)
Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models
Erika Calvo-Ochoa et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2015)
Critical analysis of Alzheimer's amyloid-beta toxicity to mitochondria
Yury G. Kaminsky et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2015)
Tau aggregation and its interplay with amyloid-β
Rebecca M. Nisbet et al.
ACTA NEUROPATHOLOGICA (2015)
On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis
Michael A. Castello et al.
AGEING RESEARCH REVIEWS (2014)
The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease
David A. Drachman
ALZHEIMERS & DEMENTIA (2014)
A Critique of the Drug Discovery and Phase 3 Clinical Programs Targeting the Amyloid Hypothesis for Alzheimer Disease
Eric Karran et al.
ANNALS OF NEUROLOGY (2014)
Interaction of Alzheimer's β-Amyloid Peptides with Cholesterol: Mechanistic Insights into Amyloid Pore Formation
Coralie Di Scala et al.
BIOCHEMISTRY (2014)
Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer's disease
Michael A. Castello et al.
BMC NEUROLOGY (2014)
Bioenergetic medicine
Russell H. Swerdlow
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Signaling pathway cross talk in Alzheimer's disease
Juan A. Godoy et al.
CELL COMMUNICATION AND SIGNALING (2014)
Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease
Fernanda G. De Felice et al.
DIABETES (2014)
Repeated intra-hippocampal injection of beta-amyloid 25-35 induces a reproducible impairment of learning and memory: Considering caspase-3 and MAPKs activity
Rasoul Ghasemi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Pathways to Alzheimer's disease
J. Hardy et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects
Robert Vassar et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Nuclear and cytosolic JNK signalling in neurons
Eleanor T. Coffey
NATURE REVIEWS NEUROSCIENCE (2014)
Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum
Juvenal A. Rios et al.
PROGRESS IN NEUROBIOLOGY (2014)
Prediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice
Juan Jose Ramos-Rodriguez et al.
PSYCHONEUROENDOCRINOLOGY (2014)
c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo
A. Sclip et al.
CELL DEATH & DISEASE (2014)
Knockout of c-Jun N-terminal kinases 1, 2 or 3 isoforms induces behavioural changes
Kirstin Reinecke et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Alzheimer's as a metabolic disease
Lloyd A. Demetrius et al.
BIOGERONTOLOGY (2013)
Mitochondrial Diseases of the Brain
Rajnish K. Chaturvedi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Evaluation of hypoxia inducible factor expression in inflammatory and neurodegenerative brain models
Maria Luisa de Lemos et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models
Bing Gong et al.
NEUROBIOLOGY OF AGING (2013)
Mitochondria and Cell Bioenergetics: Increasingly Recognized Components and a Possible Etiologic Cause of Alzheimer's Disease
Russell H. Swerdlow
ANTIOXIDANTS & REDOX SIGNALING (2012)
Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease
Baiyang Sheng et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Multiple inflammatory pathways are involved in the development and progression of cognitive deficits in APPswe/PS1dE9 mice
Wei Zhang et al.
NEUROBIOLOGY OF AGING (2012)
JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides
Sung Ok Yoon et al.
NEURON (2012)
Selective Inactivation of c-Jun NH2-Terminal Kinase in Adipose Tissue Protects Against Diet-Induced Obesity and Improves Insulin Sensitivity in Both Liver and Skeletal Muscle in Mice
Xinmei Zhang et al.
DIABETES (2011)
c-Jun N-terminal Kinase Regulates Soluble Aβ Oligomers and Cognitive Impairment in AD Mouse Model
Alessandra Sclip et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The Alzheimer's Disease Mitochondrial Cascade Hypothesis
Russell H. Swerdlow et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease
Steven P. Braithwaite et al.
NEUROBIOLOGY OF DISEASE (2010)
NEUROPROTECTION OF ETHANOL AGAINST ISCHEMIA/REPERFUSION-INDUCED BRAIN INJURY THROUGH DECREASING c-Jun N-TERMINAL KINASE 3 (JNK3) ACTIVATION BY ENHANCING GABA RELEASE
S. -H. Qi et al.
NEUROSCIENCE (2010)
cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance
Guadalupe Sabio et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin
Qiu-Lan Ma et al.
JOURNAL OF NEUROSCIENCE (2009)
JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease
Yongsheng Wang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
JNK regulates APP cleavage and degradation in a model of Alzheimer's disease
Alessio Colombo et al.
NEUROBIOLOGY OF DISEASE (2009)
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Howard Jay Aizenstein et al.
ARCHIVES OF NEUROLOGY (2008)
The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability
A. Colombo et al.
CELL DEATH AND DIFFERENTIATION (2007)
c-Jun phosphorylation in Alzheimer disease
Akanksha Thakur et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Formation of phospho-SAPK/JNK is an early event in granules in the hippocampus Alzheimer disease
Sarita Lagalwar et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Physiological regulation of the β-amyloid precursor protein signaling domain by c-Jun N-terminal kinase JNK3 during neuronal differentiation
WT Kimberly et al.
JOURNAL OF NEUROSCIENCE (2005)
c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia
V Waetzig et al.
GLIA (2005)
Block of long-term potentiation by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5
QW Wang et al.
JOURNAL OF NEUROSCIENCE (2004)
JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease
S Hunot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia
S Okuno et al.
JOURNAL OF NEUROSCIENCE (2004)
Insulin resistance due to phosphorylation of insulin receptor substrate-1 at Serine 302
ED Werner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A mitochondrial cascade hypthesis for sporadic Alzheimer's disease
RH Swerdlow et al.
MEDICAL HYPOTHESES (2004)
Targeting JNK3 for the treatment of neurodegenerative disorders
L Resnick et al.
DRUG DISCOVERY TODAY (2004)
The specificities of protein kinase inhibitors: an update
J Bain et al.
BIOCHEMICAL JOURNAL (2003)
c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade
YH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Share Paper
